These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 7922387

  • 1. Inotropic agents.
    Vincent JL, Preiser JC.
    New Horiz; 1993 Feb; 1(1):137-44. PubMed ID: 7922387
    [Abstract] [Full Text] [Related]

  • 2. [New inotropic agents in the treatment of congestive heart failure].
    Freitas M.
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
    [Abstract] [Full Text] [Related]

  • 3. Heterogeneity and prediction of hemodynamic responses to dobutamine in patients with septic shock.
    Jellema WT, Groeneveld AB, Wesseling KH, Thijs LG, Westerhof N, van Lieshout JJ.
    Crit Care Med; 2006 Sep; 34(9):2392-8. PubMed ID: 16849997
    [Abstract] [Full Text] [Related]

  • 4. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
    Schmoelz M, Schelling G, Dunker M, Irlbeck M.
    J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
    [Abstract] [Full Text] [Related]

  • 5. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE, Arlt A, Meissner A, Lins M.
    Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265
    [Abstract] [Full Text] [Related]

  • 6. Catecholamines and splanchnic perfusion.
    Meier-Hellmann A, Sakka SG, Reinhart K.
    Schweiz Med Wochenschr; 2000 Dec 16; 130(50):1942-7. PubMed ID: 11189440
    [Abstract] [Full Text] [Related]

  • 7. [Inotropic agents in advanced and refractory heart failure].
    Mangiavacchi M, Gronda E.
    Ital Heart J Suppl; 2003 Jan 16; 4(1):3-7. PubMed ID: 12690928
    [No Abstract] [Full Text] [Related]

  • 8. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock.
    Zhou SX, Qiu HB, Huang YZ, Yang Y, Zheng RQ.
    Acta Pharmacol Sin; 2002 Jul 16; 23(7):654-8. PubMed ID: 12100762
    [Abstract] [Full Text] [Related]

  • 9. Recommendations for the treatment of patients with septic shock.
    Meier-Hellmann A, Reinhart K.
    Acta Anaesthesiol Scand Suppl; 1997 Jul 16; 111():177-80. PubMed ID: 9421002
    [No Abstract] [Full Text] [Related]

  • 10. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 16; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive drugs for vasodilatory shock in ICU.
    Holmes CL, Walley KR.
    Curr Opin Crit Care; 2009 Oct 16; 15(5):398-402. PubMed ID: 19542884
    [Abstract] [Full Text] [Related]

  • 12. Inodilator therapy for heart failure. Early, late, or not at all?
    Remme WJ.
    Circulation; 1993 May 16; 87(5 Suppl):IV97-107. PubMed ID: 8097971
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan 16; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 14. Effects of epinephrine compared with the combination of dobutamine and norepinephrine on gastric perfusion in septic shock.
    Seguin P, Bellissant E, Le Tulzo Y, Laviolle B, Lessard Y, Thomas R, Mallédant Y.
    Clin Pharmacol Ther; 2002 May 16; 71(5):381-8. PubMed ID: 12011824
    [Abstract] [Full Text] [Related]

  • 15. Use of inotropes in the critical care setting.
    Löllgen H, Drexler H.
    Crit Care Med; 1990 Jan 16; 18(1 Pt 2):S56-60. PubMed ID: 2136722
    [Abstract] [Full Text] [Related]

  • 16. Inotrope/vasopressor support in sepsis-induced organ hypoperfusion.
    Vincent JL, De Backer D.
    Semin Respir Crit Care Med; 2001 Jan 16; 22(1):61-74. PubMed ID: 16088662
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic options to improve the microcirculation in sepsis and septic shock].
    Ragaller M, Theilen H, Koch T.
    Hamostaseologie; 2007 Feb 16; 27(1):59-63. PubMed ID: 17279278
    [Abstract] [Full Text] [Related]

  • 18. Nonglycoside inotropes in congestive heart failure. Are they beneficial or harmful?
    Chatterjee K, Wolfe CL, DeMarco T.
    Cardiol Clin; 1994 Feb 16; 12(1):63-72. PubMed ID: 8181026
    [Abstract] [Full Text] [Related]

  • 19. Haemodynamic management of a patient with septic shock.
    Reinhart K, Sakka SG, Meier-Hellmann A.
    Eur J Anaesthesiol; 2000 Jan 16; 17(1):6-17. PubMed ID: 10758438
    [Abstract] [Full Text] [Related]

  • 20. Diastolic arterial blood pressure: a reliable early predictor of survival in human septic shock.
    Benchekroune S, Karpati PC, Berton C, Nathan C, Mateo J, Chaara M, Riché F, Laisné MJ, Payen D, Mebazaa A.
    J Trauma; 2008 May 16; 64(5):1188-95. PubMed ID: 18469640
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.